12.02.2020
- Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s...
29.01.2020
- Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon...
11.04.2019
- Danish drugmaker Novo Nordisk plans to invest 650 million krone, or $98 million, to upgrade and expand facilities at its site in Kalundborg. The plants currently manufacture a...
15.03.2019
- Under the name INNOVO, Danish diabetes giant Novo Nordisk has launched an innovation platform for China in a drive to accelerate the transformation of scientific research into new...
16.01.2019
- Denmark’s Novo Nordisk Pharmatech has partnered with the Performance Materials business unit of DKSH, a major ingredients and specialty chemicals distributor specializing in Asia...
29.11.2018
- As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...
13.09.2018
- Ossianix, a privately held US pharmaceutical research firm based in Philadelphia, Pennsylvania, has entered a research collaboration and option agreement with Danish drugmaker Novo...
27.08.2018
- Danish pharma Novo Nordisk is boosting its efforts to develop the world’s first glucose responsive insulin and transform the treatment of diabetes following its purchase of Ziylo...
